Clinical Trial Update: A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Apatinib and Adebrelimab with chemotherapy for unresectable intrahepatic cholangiocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: RECRUITING